Live from the NIH registry
Studies recruiting near Pittsburgh right now
Top 25 of 1,243 recruiting studies, sorted by proximity — each links to its official registry page
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
University of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: University of Pennsylvania
Extracorporeal Photopheresis in Sezary Syndrome
Sezary Syndrome
N/A
Observational 20 participants sought
University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Oleg E. Akilov, MD, PhD
Pupil-Indexed Noninvasive Neuromodulation
Paresis
N/A
Interventional 110 participants sought
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: VA Office of Research and Development
A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology
Diffuse Large B Cell Lymphoma, Solid Tumor Cancer
N/A
Observational 7,000 participants sought
University of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: OWKIN
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
University of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: University of Pittsburgh
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Pittsburg, PA — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Mediar Therapeutics
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Monroeville, Pennsylvania (10.0 mi)
· Sponsor: Daiichi Sankyo
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Local Institution - 0028 — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Bristol-Myers Squibb
Spinal Cord Stimulation for Children With Cerebral Palsy
Cerebral Palsy, Spasticity
N/A
Interventional 30 participants sought
UPMC Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Martin Piazza
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes
Phase 2
Interventional 100 participants sought
UPMC Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Paul Szabolcs
Amish/Mennonite Research Contact Registry
All
N/A
Observational 1,000 participants sought
Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: University of Pittsburgh
Acoustic Stimulation, Sleep, and Cognitive-Emotional Processes in Young Adults With Anxiety and Depression Symptoms
Acoustic Stimulation
N/A
Interventional 40 participants sought
University of Pittsburgh — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Michelle Stepan
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 168 participants sought
Allegheny Health Network — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: OncoNano Medicine, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Thrombocythemia, Essential, Primary Myelofibrosis
Phase 3
Interventional 400 participants sought
UPMC Hillman Cancer Center ( Site 6004) — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Sameek Roychowdhury
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase 3
Interventional 117 participants sought
UPMC Children's Hospital of Pittsburgh - Cardiology — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Bayer
A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer
Cancer, Breast Cancer
N/A
Interventional 21 participants sought
AHN Allegheny General Hospital — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
University of Pittsburgh Medical Center (Adults only) — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Pierre Fabre Medicament
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UPMC-Saint Margaret — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Allegheny General Hospital — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Allegheny Health Network — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: University of Alabama at Birmingham
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Delirium, Neurocognitive Disorders
N/A
Interventional 1,900 participants sought
Allegheny General Hospital — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: University of Michigan
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: Amgen
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Pittsburgh, Pennsylvania (1.0 mi)
· Sponsor: AstraZeneca